Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for chronic central serous chorioretinopathy
ChiCTR1800019084Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of spironolactone in Central Serous Chorioretinopathy (CSCR), sponsored by West China Hospital of Sichuan University. Primary endpoint: Area of subretinal fluid. Started Jul 2018; status: recruiting.
02
Drugs
spironolactone
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on ChiCTR1800019084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019084.